Revelation Biosciences, Inc. Unit
REVBU
REVBU was delisted on the 11th of January, 2023.
0 hedge funds and large institutions have $0 invested in Revelation Biosciences, Inc. Unit in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $58K → $0 (-$58K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CFN
Cordasco Financial Network
Naples,
Florida
|
-$58K |
REVBU Hedge Fund Activity: Q1 2022 in Review
0 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences, Inc. Unit (REVBU) for Q1 2022, worth a combined $0 — down 100% from $58K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of REVBU and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Cordasco Financial Network, exiting entirely with an estimated $58K sold.
- 0 institutional investors held Revelation Biosciences, Inc. Unit (REVBU) as of Q1 2022, down from 1 in Q4 2021.
- Funds reported $0 of Revelation Biosciences, Inc. Unit stock for Q1 2022, down 100% quarter-over-quarter.
- 0 funds opened new Revelation Biosciences, Inc. Unit positions in Q1 2022 and 1 closed out, a net change of -1 holder.
- The largest Revelation Biosciences, Inc. Unit seller in Q1 2022 was Cordasco Financial Network, an estimated $58K sold.
Based on aggregated 13F filings for Q1 2022.